Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 3:01 PM
Ignite Modification Date: 2025-12-25 @ 1:24 PM
NCT ID: NCT04558359
Description: Targeted screening for venous thromboembolism, arrhythmia, extremity hypoperfusion, delirium, new ischemic event, new infection from enrollment up to 72 hours following shock resolution.
Frequency Threshold: 0
Time Frame: Up to 72 hours following shock resolution, no longer than 17 days from enrollment
Study: NCT04558359
Study Brief: Renin and Renal Biomarker Response to Angiotensin II
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Standard of Care Cohort Patients in this group will receive standard of care treatment. Standard of Care: These patients will receive standard of care treatment. Plasma renin levels and biomarkers of renal function will be measured. 9 None 0 10 0 10 View
Angiotensin II Cohort Patients in this group will receive angiotensin II. Angiotensin II: These patients will receive angiotensin II in addition to standard of care treatment. Plasma renin levels and biomarkers of renal function will be measured. 9 None 0 18 0 18 View
Serious Events(If Any):
Other Events(If Any):